NCT00870103View on ClinicalTrials.gov

Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

February 28, 2009

Conditions
Cataract
Interventions
DRUG

Vigadexa (moxifloxacin 0.5% and dexamethasone 0.1%) eye drops

1 drop every 6 hours into the study eye

Trial Locations (1)

76134

Alcon Call Center, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY